Pure Global

BD 革蘭氏陰性菌藥物敏感性試劑組-β-內醯胺複合藥類 - Taiwan Registration 15c221d0daa544a22d02d2f095abebe2

Access comprehensive regulatory information for BD 革蘭氏陰性菌藥物敏感性試劑組-β-內醯胺複合藥類 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 15c221d0daa544a22d02d2f095abebe2 and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
15c221d0daa544a22d02d2f095abebe2
Registration Details
Taiwan FDA Registration: 15c221d0daa544a22d02d2f095abebe2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BD 革蘭氏陰性菌藥物敏感性試劑組-β-內醯胺複合藥類
Risk Class 2

Registration Details

15c221d0daa544a22d02d2f095abebe2

DHA05603751105

Company Information

Product Details

This product contains selective antimicrobials (listed in Table 1 of the instructions) for drug tolerance testing against most gram-negative aerobic and facultative anaerobes, and must be used with the Phoenix Automated Microbiological System instrument.

C Immunology and microbiology

C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period

Input;; QMS/QSD

Dates and Status

Nov 06, 2024

Nov 06, 2029